Lateral Flow Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Kits & Reagents, Lateral Flow Readers, and Others), By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, and Others), By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay), By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Region and Competition
The Global Lateral Flow Assay Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of infectious diseases such as TB, Hepatitis, and Influenza STI, along with the growing demand for point-of-care testing. Similarly, the growing adoption of new technology like lateral flow assay kits is expected to create significant growth during the forecast period. Additionally, growing geriatric populations are susceptible to different types of chronic diseases, which enhances the demand for home-based testing methods. This, in turn, is expected to boost market growth during the forecast period. Besides, growing public awareness about the new testing assay is also propelling market growth through 2028. , during the 2019-2020 flu season, there were 36 million cases of influenza in the United States. The number of influenza deaths during the 2019-2020 flu season was 20,342. The vast majority of deaths attributed to influenza during the 2019-2020 flu season occurred among those aged 65 years and older.
Growing prevalence of infectious diseases
Chronic illnesses such as cystic fibrosis, cardiovascular diseases, hepatitis, and cancer are rapidly increasing due to physiological changes, metabolic problems, and low immune systems, and so the aging population is prone to these types of chronic diseases, which will enhance the growth of the market during the forecast period. Similarly, changing a healthy lifestyle will enhance disease growth across the region, and this, in turn, will boost the market growth during the forecast period. In September 2020, Qiagen N.V. bought NeuMoDx Molecular, Inc. to expand Qiagen's diagnostics instrument product line and boost its market position in automated molecular testing. This will broaden QIAGEN's offering of automated testing solutions and serve as another catalyst for future growth. Government initiative and awareness about using new assays will boost the market growth during the forecast period. During 2021, a total of 7,860 TB cases were provisionally reported to CDC’s National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC). The increasing prevalence of infectious diseases like HIV and malaria due to consuming unhealthy food is expected to create lucrative growth during the forecast period. Due to the increasing prevalence of chronic diseases, demand leading a healthy lifestyle increased, which is further expected to drive the growth of the market over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions.
Increasing demand for home-based testing method
Rising demand for home-based testing kits for the detection of chronic diseases, pregnancy tests, fertility tests, coagulation tests, urine chemistry, etc., the growing demand for point-of-care testing may further enhance the demand for lateral flow assay, and usage of this device is rapidly increased which may further propel the growth of the market during the forecast period. According to this Statista, 7.92 million women in the U.S. used home pregnancy tests in 2020. Major companies are focusing on developing innovative lateral flow assay-based point-of-care devices for applications such as pregnancy tests by using HCG levels and ovulation, careening for infectious diseases ad drugs, and the measurement of protein markers in the boost is expected to enhance the demand for lateral flow assay market over the years. For instance, in 2019, Abbott Laboratories (US) developed its ARCHITECT stat Troponin I blood test, while Siemens AG developed the CLINITEK Microalbumin 2 strips for clinical diagnostics.
Market Segmentation
The global lateral flow assay market can be segmented by product, application, technique, test type, end-user, and by region. Based on the product, the market can be segmented into Kits & Reagents, Lateral Flow Readers, and Others. Based on application, the market can be segmented into Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, and Others. Based on technique, the market can be differentiated by Sandwich Assay, Competitive Assay, and Multiplex Detection Assay. Based on test type, the market can be divided into Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay. Based on end-user, the market can be differentiated into Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among different countries, the United States dominates the global lateral flow assay market on account of the growing prevalence of infectious diseases and the demand for new technology with affordable costs in the country. Reported TB incidence (cases per 100,000 persons) increased by 9.4%, from 2.2 in 2020 to 2.4 in 2021 but was lower than incidence during 2019 (2.7). Increases occurred among both U.S.-born and non–U.S.-born persons.
Market Players
Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMйrieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V. are some of the leading players operating in the Global Lateral Flow Assay Market.
Recent Development
Novacyt, a specialist in clinical diagnostics, is to launch two PathFlow COVID-19 antigen lateral flow tests (LFTs) to strengthen its COVID-19 portfolio and to pursue new market opportunities, especially in point-of-care (POC) settings. In September 2020, F. Hoffmann-La Roche AG (Switzerland) launched a SARS-CoV-2 rapid antigen test kit and a SARS-CoV-2 rapid antibody test kit.
Report Scope:
In this report, the global lateral flow assay market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Lateral Flow Assay Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Growing prevalence of infectious diseases
Chronic illnesses such as cystic fibrosis, cardiovascular diseases, hepatitis, and cancer are rapidly increasing due to physiological changes, metabolic problems, and low immune systems, and so the aging population is prone to these types of chronic diseases, which will enhance the growth of the market during the forecast period. Similarly, changing a healthy lifestyle will enhance disease growth across the region, and this, in turn, will boost the market growth during the forecast period. In September 2020, Qiagen N.V. bought NeuMoDx Molecular, Inc. to expand Qiagen's diagnostics instrument product line and boost its market position in automated molecular testing. This will broaden QIAGEN's offering of automated testing solutions and serve as another catalyst for future growth. Government initiative and awareness about using new assays will boost the market growth during the forecast period. During 2021, a total of 7,860 TB cases were provisionally reported to CDC’s National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC). The increasing prevalence of infectious diseases like HIV and malaria due to consuming unhealthy food is expected to create lucrative growth during the forecast period. Due to the increasing prevalence of chronic diseases, demand leading a healthy lifestyle increased, which is further expected to drive the growth of the market over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions.
Increasing demand for home-based testing method
Rising demand for home-based testing kits for the detection of chronic diseases, pregnancy tests, fertility tests, coagulation tests, urine chemistry, etc., the growing demand for point-of-care testing may further enhance the demand for lateral flow assay, and usage of this device is rapidly increased which may further propel the growth of the market during the forecast period. According to this Statista, 7.92 million women in the U.S. used home pregnancy tests in 2020. Major companies are focusing on developing innovative lateral flow assay-based point-of-care devices for applications such as pregnancy tests by using HCG levels and ovulation, careening for infectious diseases ad drugs, and the measurement of protein markers in the boost is expected to enhance the demand for lateral flow assay market over the years. For instance, in 2019, Abbott Laboratories (US) developed its ARCHITECT stat Troponin I blood test, while Siemens AG developed the CLINITEK Microalbumin 2 strips for clinical diagnostics.
Market Segmentation
The global lateral flow assay market can be segmented by product, application, technique, test type, end-user, and by region. Based on the product, the market can be segmented into Kits & Reagents, Lateral Flow Readers, and Others. Based on application, the market can be segmented into Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, and Others. Based on technique, the market can be differentiated by Sandwich Assay, Competitive Assay, and Multiplex Detection Assay. Based on test type, the market can be divided into Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay. Based on end-user, the market can be differentiated into Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among different countries, the United States dominates the global lateral flow assay market on account of the growing prevalence of infectious diseases and the demand for new technology with affordable costs in the country. Reported TB incidence (cases per 100,000 persons) increased by 9.4%, from 2.2 in 2020 to 2.4 in 2021 but was lower than incidence during 2019 (2.7). Increases occurred among both U.S.-born and non–U.S.-born persons.
Market Players
Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMйrieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V. are some of the leading players operating in the Global Lateral Flow Assay Market.
Recent Development
Novacyt, a specialist in clinical diagnostics, is to launch two PathFlow COVID-19 antigen lateral flow tests (LFTs) to strengthen its COVID-19 portfolio and to pursue new market opportunities, especially in point-of-care (POC) settings. In September 2020, F. Hoffmann-La Roche AG (Switzerland) launched a SARS-CoV-2 rapid antigen test kit and a SARS-CoV-2 rapid antibody test kit.
Report Scope:
In this report, the global lateral flow assay market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Lateral Flow Assay Market, By Product:
- Kits & Reagents
- Lateral Flow Readers
- Others
- Lateral Flow Assay Market, By Application:
- Clinical Testing
- Cardiac Marker Testing
- Pregnancy & Fertility Testing
- Veterinary Diagnostics
- Others
- Lateral Flow Assay Market, By Technique:
- Sandwich Assay
- Competitive Assay
- Multiplex Detection Assay
- Lateral Flow Assay Market, By Test Type:
- Lateral Flow Immunoassay
- Nucleic Acid Lateral Flow Assay
- Lateral Flow Assay Market, By End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- Lateral Flow Assay Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Lateral Flow Assay Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL LATERAL FLOW ASSAY MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
5.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
5.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
5.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
5.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
5.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
5.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
5.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By Technique
5.3.4. By Test Type
5.3.5. By End User
5.3.6. By Region
6. NORTH AMERICA LATERAL FLOW ASSAY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
6.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
6.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
6.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
6.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
6.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
6.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
6.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Lateral Flow Assay Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Technique
6.3.1.2.4. By Test Type
6.3.1.2.5. By End User
6.3.2. Mexico Lateral Flow Assay Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Technique
6.3.2.2.4. By Test Type
6.3.2.2.5. By End User
6.3.3. Canada Lateral Flow Assay Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Technique
6.3.3.2.4. By Test Type
6.3.3.2.5. By End User
7. EUROPE LATERAL FLOW ASSAY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
7.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
7.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
7.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
7.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
7.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
7.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
7.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Lateral Flow Assay Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Test Type
7.3.1.2.5. By End User
7.3.2. Germany Lateral Flow Assay Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Test Type
7.3.2.2.5. By End User
7.3.3. United Kingdom Lateral Flow Assay Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Test Type
7.3.3.2.5. By End User
7.3.4. Italy Lateral Flow Assay Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.4.2.4. By Test Type
7.3.4.2.5. By End User
7.3.5. Spain Lateral Flow Assay Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
7.3.5.2.4. By Test Type
7.3.5.2.5. By End User
8. ASIA-PACIFIC LATERAL FLOW ASSAY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
8.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
8.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
8.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
8.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
8.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
8.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
8.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Lateral Flow Assay Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Test Type
8.3.1.2.5. By End User
8.3.2. India Lateral Flow Assay Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Test Type
8.3.2.2.5. By End User
8.3.3. South Korea Lateral Flow Assay Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Test Type
8.3.3.2.5. By End User
8.3.4. Japan Lateral Flow Assay Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Test Type
8.3.4.2.5. By End User
8.3.5. Australia Lateral Flow Assay Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Test Type
8.3.5.2.5. By End User
9. SOUTH AMERICA LATERAL FLOW ASSAY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
9.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
9.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
9.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
9.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
9.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
9.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
9.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Lateral Flow Assay Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Test Type
9.3.1.2.5. By End User
9.3.2. Argentina Lateral Flow Assay Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Test Type
9.3.2.2.5. By End User
9.3.3. Colombia Lateral Flow Assay Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Test Type
9.3.3.2.5. By End User
10. MIDDLE EAST AND AFRICA LATERAL FLOW ASSAY MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
10.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
10.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
10.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
10.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
10.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
10.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
10.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Lateral Flow Assay Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Test Type
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Lateral Flow Assay Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Test Type
10.3.2.2.5. By End User
10.3.3. UAE Lateral Flow Assay Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Test Type
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. GLOBAL LATERAL FLOW ASSAY MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 Thermo Fisher Scientific, Inc.
15.6.2 Abbott Laboratories, Inc.
15.6.3 F. Hoffmann-La Roche AG
15.6.4 Bio-Rad Laboratories, Inc.
15.6.5 Quidel Corporation
15.6.6 Hologic, Inc.
15.6.7 bioMйrieux SA
15.6.8 PerkinElmer, Inc.
15.6.9 Danaher Corporation
15.6.10 QIAGEN N.V.
16. STRATEGIC RECOMMENDATIONS
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL LATERAL FLOW ASSAY MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
5.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
5.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
5.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
5.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
5.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
5.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
5.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By Technique
5.3.4. By Test Type
5.3.5. By End User
5.3.6. By Region
6. NORTH AMERICA LATERAL FLOW ASSAY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
6.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
6.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
6.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
6.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
6.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
6.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
6.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Lateral Flow Assay Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Technique
6.3.1.2.4. By Test Type
6.3.1.2.5. By End User
6.3.2. Mexico Lateral Flow Assay Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Technique
6.3.2.2.4. By Test Type
6.3.2.2.5. By End User
6.3.3. Canada Lateral Flow Assay Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Technique
6.3.3.2.4. By Test Type
6.3.3.2.5. By End User
7. EUROPE LATERAL FLOW ASSAY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
7.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
7.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
7.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
7.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
7.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
7.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
7.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Lateral Flow Assay Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Test Type
7.3.1.2.5. By End User
7.3.2. Germany Lateral Flow Assay Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Test Type
7.3.2.2.5. By End User
7.3.3. United Kingdom Lateral Flow Assay Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Test Type
7.3.3.2.5. By End User
7.3.4. Italy Lateral Flow Assay Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.4.2.4. By Test Type
7.3.4.2.5. By End User
7.3.5. Spain Lateral Flow Assay Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
7.3.5.2.4. By Test Type
7.3.5.2.5. By End User
8. ASIA-PACIFIC LATERAL FLOW ASSAY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
8.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
8.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
8.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
8.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
8.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
8.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
8.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Lateral Flow Assay Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Test Type
8.3.1.2.5. By End User
8.3.2. India Lateral Flow Assay Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Test Type
8.3.2.2.5. By End User
8.3.3. South Korea Lateral Flow Assay Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Test Type
8.3.3.2.5. By End User
8.3.4. Japan Lateral Flow Assay Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Test Type
8.3.4.2.5. By End User
8.3.5. Australia Lateral Flow Assay Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Test Type
8.3.5.2.5. By End User
9. SOUTH AMERICA LATERAL FLOW ASSAY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
9.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
9.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
9.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
9.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
9.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
9.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
9.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Lateral Flow Assay Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Test Type
9.3.1.2.5. By End User
9.3.2. Argentina Lateral Flow Assay Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Test Type
9.3.2.2.5. By End User
9.3.3. Colombia Lateral Flow Assay Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Test Type
9.3.3.2.5. By End User
10. MIDDLE EAST AND AFRICA LATERAL FLOW ASSAY MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
10.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
10.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
10.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
10.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
10.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
10.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
10.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Lateral Flow Assay Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Test Type
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Lateral Flow Assay Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Test Type
10.3.2.2.5. By End User
10.3.3. UAE Lateral Flow Assay Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Test Type
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. GLOBAL LATERAL FLOW ASSAY MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 Thermo Fisher Scientific, Inc.
15.6.2 Abbott Laboratories, Inc.
15.6.3 F. Hoffmann-La Roche AG
15.6.4 Bio-Rad Laboratories, Inc.
15.6.5 Quidel Corporation
15.6.6 Hologic, Inc.
15.6.7 bioMйrieux SA
15.6.8 PerkinElmer, Inc.
15.6.9 Danaher Corporation
15.6.10 QIAGEN N.V.
16. STRATEGIC RECOMMENDATIONS
